About Satipharm
Satipharm is a company based in Cham (Switzerland) founded in 2011 was acquired by Cann Group in February 2021. Satipharm offers products and services including CBD Capsules and Gelpell Technology. Satipharm operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
- Headquarter Cham, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Cann Group
(Feb 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Satipharm
Satipharm offers a comprehensive portfolio of products and services, including CBD Capsules and Gelpell Technology.
Capsules that enhance CBD bioavailability for health benefits.
Technology for improving CBD absorption in products.
Funding Insights of Satipharm
Detailed funding history for Satipharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Satipharm
Satipharm has secured backing from 1 investor. Prominent investors backing the company include Cann Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis research services for medical purposes are provided.
|
Locked | Locked | Locked |
Investor details for Satipharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Satipharm
Investment portfolio details for Satipharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Satipharm
Detailed financials for Satipharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Satipharm Comparisons
Peer comparison for Satipharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Satipharm
Satipharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| Locked | Locked | Locked |
Nutritional ingredients for health and wellness are developed.
|
|
| Locked | Locked | Locked |
Dietary supplements, diet foods, health products, and medical devices
|
|
| Locked | Locked | Locked |
Nutritional products for various health ailments are provided.
|
|
| Locked | Locked | Locked |
Personalized wellness solutions are delivered via a digital healthcare platform.
|
|
| Locked | Locked | Locked |
Nutritional supplements are provided to enhance health and wellness.
|
Detailed competitors of Satipharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Satipharm
Complete news archive for Satipharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satipharm
Satipharm was founded in 2011.
Satipharm is headquartered in Cham, Switzerland. It is registered at Cham, Zug, Switzerland.
Satipharm was founded in 2011 in Cham, Switzerland, where medical cannabidiol supplements are produced and distributed. Operations focus on variants of 10mg and 50mg, with packs priced at EUR49 and EUR199 respectively. Products are sold online and via retail pharmacies in Germany. Manufacturing occurs in Swiss GMP-certified facilities within the health supplements sector.
Satipharm offers CBD Capsules and Gelpell Technology.
Satipharm has 1 investor. Key investors include Cann Group.